Logo

HIT

Health In Tech, Inc.

HIT

Health In Tech, Inc. • NASDAQ
$1.52 ▲ 2.70% (+0.04)
Market Cap $86.50 M
52w High $7.59
52w Low $0.51
Dividend Yield 0%
P/E 76
Volume 63.17K
Outstanding Shares 56.91M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $8.49M ▼ $4.65M ▼ $452.176K ▼ 5.326% ▼ $0.01 ▼ $818.203K ▼
Q2-2025 $9.314M ▲ $5.585M ▲ $630.631K ▲ 6.771% ▲ $0.011 ▲ $969.251K ▲
Q1-2025 $8.015M ▲ $4.875M ▲ $498.592K ▲ 6.221% ▲ $0.009 ▲ $820.406K ▲
Q4-2024 $4.905M ▲ $4.114M ▲ $-144.152K ▼ -2.939% ▼ $-0.003 ▼ $25.235K ▼
Q3-2024 $4.459M $3.04M $376.086K 8.434% $0.007 $707.323K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $8.024M ▼ $22.756M ▲ $5.597M ▼ $17.159M ▲
Q2-2025 $8.138M ▲ $22.178M ▲ $5.755M ▼ $16.424M ▲
Q1-2025 $7.575M ▼ $21.33M ▲ $7.169M ▲ $14.161M ▲
Q4-2024 $7.849M ▲ $15.768M ▲ $2.599M ▼ $13.169M ▲
Q3-2024 $1.747M $9.672M $2.765M $6.908M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $452.176K ▼ $673.973K ▼ $-744.841K ▲ $-43.685K ▼ $-114.553K ▼ $2.287M ▲
Q2-2025 $630.631K ▲ $1.481M ▲ $-909.897K ▼ $-8.25K ▲ $563.129K ▲ $571.379K ▲
Q1-2025 $498.592K ▲ $527.353K ▲ $-703.475K ▼ $-98.089K ▼ $-274.211K ▼ $-176.122K ▲
Q4-2024 $-144.152K ▼ $-531.167K ▼ $-542.121K ▼ $7.175M ▲ $6.102M ▲ $-1.137M ▼
Q3-2024 $376.086K $2.121M $-67.278K $-2.47M $-415.975K $2.054M

Five-Year Company Overview

Income Statement

Income Statement Health In Tech’s reported income statement is still at a very early stage. Revenue is small but has been creeping up, and gross profit roughly tracks revenue, suggesting a light cost structure and a largely software-driven model. Operating and net income hover around breakeven, which is common for a young tech platform still building scale. The limited history and very small base mean that any change—good or bad—can look dramatic on paper, so trends should be read with caution. Overall, this looks like a business still in its “build-out” phase rather than one focused on mature profitability.

Balance Sheet

Balance Sheet The balance sheet is lean and simple. Assets are modest, with some cash on hand, and there is effectively no financial debt, which reduces balance sheet risk but also signals that the company may be relying more on equity or internal resources than on borrowing. Equity is positive but thin, reflecting an early-stage company that hasn’t yet accumulated large retained earnings. With such a small asset base, the business doesn’t appear capital-intensive, but it is also more exposed to swings in working capital and funding needs as it grows.

Cash Flow

Cash Flow Reported cash flows are essentially flat, with little visible operating cash generation and negligible spending on long‑term assets. That suggests the core business has not yet scaled to a point where it throws off meaningful cash, nor is the company heavily investing in physical infrastructure. Most of the value creation is likely happening in software development, data, and partnerships rather than in hard assets. For now, the cash picture looks stable but unproven; future periods will be important to see whether revenue growth translates into consistent operating cash inflows.

Competitive Edge

Competitive Edge Health In Tech operates in a focused niche: technology for self‑funded and level‑funded health plans, especially for smaller and midsized employers. Its main strength is speed and automation in underwriting, using AI to turn complex health and claims data into fast, bindable quotes for brokers. The company further differentiates itself through vertical integration—combining quoting technology, stop‑loss coverage, a provider network, and benefits tools into one ecosystem. This can create stickiness with brokers and employers, especially in a part of the market that big insurers often under-serve. The flip side is that Health In Tech operates in a highly regulated, competitive space with large incumbents and newer insurtech rivals. Its ability to keep expanding distribution, win larger employer groups, and maintain pricing power will be key to sustaining this competitive edge.

Innovation and R&D

Innovation and R&D Innovation is the centerpiece of Health In Tech’s story. Its eDIYBS platform uses AI for underwriting and automated data intake, turning messy claims files into structured data quickly. This improves speed, accuracy, and broker productivity. The company also layers on products like its HI Card, a curated provider network, and a growing menu of ancillary benefits, which deepen its role in the benefits stack. On top of that, it is exploring telehealth integrations and talking about blockchain solutions for security and transparency, signaling a willingness to push into emerging technologies. The main question is execution: can the company keep expanding its platform, maintain reliability and compliance, and convert these innovations into durable customer relationships and recurring revenue?

Summary

Health In Tech is an early‑stage, technology‑driven insurtech with small but growing revenues, a light and mostly clean balance sheet, and no meaningful history yet of strong cash generation. Financial statements today tell more of a “startup profile” than a mature operating story. The real interest lies in its strategic positioning: a vertically integrated, AI‑led platform targeted at an underserved corner of the health insurance market, sold through brokers and partners. If the company can scale its distribution, win in larger employer segments, and keep innovating while managing regulatory and competitive pressures, its fundamentals could change quickly. Until then, both the upside and the risk remain high, and reported numbers should be viewed as an early snapshot rather than a steady long‑term pattern.

NEWS

November 20, 2025 · 7:18 PM UTC

AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion Clarification and Correction

Read more

November 11, 2025 · 7:00 AM UTC

Health In Tech and AlphaTON Capital to Unveil Blockchain Healthcare Vision at Web Summit Lisbon

Read more

November 10, 2025 · 4:00 PM UTC

Health In Tech Announces Third Quarter 2025 Financial Results

Read more

November 4, 2025 · 7:30 PM UTC

TIME CEO Jessica Sibley to Headline Health In Tech (HIT) Summit at Davos 2026: "AI and the Transformation of Legacy Systems"

Read more

November 4, 2025 · 6:48 PM UTC

Health In Tech Announces New Davos 2026 Panel: "First Ladies: Backing Women Who Build" Featuring Cherie Blair CBE, KC

Read more